This communication is being sent on behalf of Margaret Williams.
On the 17th of February, a press conference was held at the Science Media Centre to announce the e-publication of the PACE Trial in the Lancet the following day. The Science Media Centre themselves issued the following press release which has just entered the public domain. For background information on the SMC please see below.
Expert reaction to Lancet study looking at treatments for Chronic Fatigue Syndrome/ME
The study made the first definitive comparison of various treatments for CFS/ME to deduce the most effective treatments.
Dr Alastair Miller, Consultant Physician at Royal Liverpool University Hospital, Clinical lead for CFS services in Liverpool, Independent assessor of trial safety data for PACE trial and Principal Medical Advisor, Action for ME, said "Although NICE have previously recommended graded exercise and CBT as treatments for ME/CFS, this was on the basis of somewhat limited evidence in the form of fairly small clinical trials. This trial represents the highest grade of clinical evidence – a large randomized clinical trial, carefully designed, rigorously conducted and scrupulously analysed and reported. It provides convincing evidence that GET and CBT are safe and effective and should be widely available for our patients with CFS/ME.
"It is clearly vital to continue our research into biological mechanisms for ME/CFS but recent 'false dawns' for example, over the role of retroviruses (XMRV) have shown how difficult this can be. In the current absence of a biomedical model for the causation and the absence of any pharmacological intervention, we have a pragmaticapproach to therapy that works and we should use it." Read more »